Prot #NIR-DT-301: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients with Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/14/19 → 4/15/23

Funding

  • Medpace Clinical Research LLC ((OE) Prot #NIR-DT-301 // (OE) Prot #NIR-DT-301)
  • SpringWorks Subsidiary 2, PBC ((OE) Prot #NIR-DT-301 // (OE) Prot #NIR-DT-301)